A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics
Thermo Fisher Scientific Receives First FBI Approval for Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations
Palantir's Bold Biosecurity Opportunity Could Be Bigger Than Investors Think
FTAI Aviation: Innovation Is Their DNA
Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights
Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China
DNA X, Inc. Reports First Quarter 2026 Financial Results
DNA Finland Extends Fiber-Grade Connectivity to Lower-Density MDUs with Harmonic
Ginkgo Bioworks: Another Lost Year
The $59B Quiet Shift Reshaping How Patients Access Care
Lotus Unveils Focus 2030 – Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar
Ginkgo Bioworks Q1 Earnings Call Highlights
Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation
DNA X, Inc. Reports Full Year 2025 Financial Results
Ginkgo Bioworks (NYSE:DNA) Insider Reshma Shetty Sells 124,727 Shares
Ginkgo Bioworks (NYSE:DNA) Major Shareholder Sells $91,164.15 in Stock
Ginkgo Bioworks (NYSE:DNA) Insider Sells $91,164.15 in Stock
Insider Selling: Ginkgo Bioworks (NYSE:DNA) Major Shareholder Sells $83,942.40 in Stock
TelevisaUnivision Bets Its Telenovela DNA Can Win The Microdrama Race
Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen
Ginkgo Bioworks Makes Major Pivot
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2025 Earnings Call Transcript
Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts
Amazon's DNA: Why Hoarding Cash Is Secondary To Building Empires
Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know
Allegiant Travel: Cost Discipline DNA Returns, Sun Country Airlines' Upside
Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark
Why Ginkgo Bioworks Holdings, Inc. (DNA) Dipped More Than Broader Market Today
Ginkgo Bioworks Holdings, Inc. (DNA) Declines More Than Market: Some Information for Investors
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to Note
Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to Know
MySize Explores Unlocking the "DNA of Fashion" Through Privacy-First Data Intelligence
Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach
Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment
Thermo Fisher Scientific Expands Gibco™ Bacto™ Portfolio with Next-Generation, Chemically Defined Media to Boost E. coli Biomanufacturing Productivity
ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies